Phospholamban Cardiomyopathy Leading to Advanced Heart Failure in an Active Duty Service Member
Ryan Choi1, Robert N Geis2, Satoshi Shin2
1Department of Internal Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USA.
Insights
A rare phospholamban mutation caused severe heart failure in a young service member with familial dilated cardiomyopathy (DCM). Genetic screening is crucial for DCM families, highlighting a gap in military medical standards.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a severe heart condition.
- Genetic mutations, such as in phospholamban, are rare causes of DCM.
- Familial DCM can present in young individuals.
Purpose of the Study:
- To report a case of a young service member with familial DCM.
- To emphasize the role of phospholamban mutations in DCM.
- To highlight the need for genetic screening and updated military medical standards.
Main Methods:
- Case report of a young service member.
- Clinical presentation and diagnostic workup for advanced heart failure.
- Identification of an autosomal dominant phospholamban mutation.
Main Results:
- The patient presented with advanced heart failure due to familial DCM.
- An autosomal dominant phospholamban mutation was identified as the cause.
- Successful heart transplantation was performed 23 days after presentation.
Conclusions:
- Phospholamban mutations are a significant, albeit rare, cause of DCM.
- Genetic screening and surveillance are vital for families with a history of DCM.
- Current military accession medical standards may need revision to include genetic screening for conditions like DCM.
Abstract:
A phospholamban mutation is a rare genetic cause of dilated cardiomyopathy (DCM). Our case describes a young service member who presented with advanced heart failure and was found to have a familial DCM from an autosomal dominant phospholamban mutation. He ultimately underwent a successful heart transplant just 23 days after his initial presentation. This case highlights the importance of genetic screening and surveillance for patients with a family history of DCM, and it identifies a gap in medical standards for military accession.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Satellite Stem Cells and Muscular Dystrophy


